Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal and Observational Natural History Study for Children and Adults With Baker Gordon Syndrome - Genetic Autism Alliance

NCT06399952 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT06399952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal and Observational Natural History Study for Children and Adults With Baker Gordon Syndrome - Genetic Autism Alliance
Lead sponsor
University of Missouri-Columbia
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2024
Completion date
May 5, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism or autistic traits, development delay, epilepsy, generalized, motor delay, rare diseases, sleep disorder, syt-ssx fusion protein expression